Using Mother's Raw Milk Could Improve Breastfeeding in Hospitalized Neonates (DOAL)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Breastfeeding

Treatments

Other: raw mother's own milk

Study type

Observational

Funder types

Other

Identifiers

NCT02819193
69HCL16_0379

Details and patient eligibility

About

Despite the importance of breast milk for sick or preterm neonates, there is currently no consensus regarding the use of raw mother's own milk (MOM) in neonatal units. The aims of this study are to: (a) describe factors associated with the use of raw MOM; (b) investigate the association between early use of raw MOM and breastfeeding continuation at discharge and up to 6 months later.

Enrollment

665 patients

Sex

All

Ages

Under 42 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

Admitted neonates between April 2012 and June 2013 are eligible if they are intended to be breastfeed and hospitalized ≥7 days

Exclusion criteria

- Neonates with parents not fluent in French.

Trial design

665 participants in 2 patient groups

exposed group : early raw mother's own milk
Description:
The use of raw MOM is considered as "early" when it begins before day 7.
Treatment:
Other: raw mother's own milk
unexposed group : no use of raw mother's own milk
Description:
Neonates who receive, or not, raw MOM before day 7.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems